Special Issue "Polymeric Nanoparticles for Cancer Treatment"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".

Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 118

Special Issue Editors

Instituto Botánico, Departamento de Ciencia y Tecnología Agroforestal y Genética, Universidad de Castilla-La Mancha, Campus Universitario s/n, 02071 Albacete, Spain
Interests: plant biotechnology; nanotechnology; green nanotechnology; DNA delivery; nanomedicine in cancer
Oncología traslacional, Unidad de Investigación del Complejo Hospitalario Universitario de Albacete, 02008 Albacete, Spain
Interests: cancer research; nanomedicine; cancer immunotherapy; drug conjugates; diagnosis; lipid nanoparticles; polymer nanoparticles

Special Issue Information

Dear Colleagues,

Currently, the use of nanotechnology as a promising tool in cancer treatment is becoming a reality. Polymers have emerged as one of the most important and versatile raw materials to obtain novel nanovehicles to treat different types of cancer. The easy modification of different functional groups and polymeric chains can provide many types of polymers with a wide range of solubilities, including stimulus-responsive polymers that can allow selective drug release in different microenvironments and also the incorporation of various biomolecules to obtain smart nanovehicles, improving the selectivity and efficiency of nanosystems.

The search for new polymers that can be approved by different regulatory agencies for use as a raw material to obtain new nanoparticles for cancer treatment is currently an important topic in nanomedicine. In addition, establishing new methods for polymeric nanoparticle formulation, the encapsulation of new drugs and the modification of nanoparticles with different biomolecules to achieve more selective cancer treatment is a necessity.

Authors are kindly invited to submit original and novel works regarding the promising  application of polymeric nanoparticles for cancer treatment, to be published in this Special Issue of Pharmaceutics.

Dr. Enrique Niza
Dr. Francisco J. Cimas
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • polymers
  • polymeric nanoparticles
  • nanotechnology
  • cancer
  • smart nanoparticles
  • antitumor

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop